This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Thakore, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thakore, J. H.
The British Journal of Psychiatry (2004) 184: s76-S79
© 2004 The Royal College of Psychiatrists

Metabolic disturbance in first-episode schizophrenia

Jogin H. Thakore, PhD MRCPI MRCPsych

Senior Lecturer in Psychiatry, Royal College of Surgeons in Ireland; Neuroscience Centre, St Vincent’s Hospital, Richmond Road, Fairview, Dublin 3, Ireland.

Correspondence: Tel: +353 1 884 2400; fax: +353 1 884 2450; E-mail: jthakore{at}rcsi.ie

Declaration of interest J.H.T. is supported by a grant from Eli Lilly & Co.

Background Schizophrenia shortens life, e.g. through suicide and obesity-related diseases such as type 2 diabetes mellitus. It is assumed that medications play a major role, but most of the evidence for this comes from studies poorly controlled for variables such as lifestyle and medication status.

Aims To determine whether schizophrenia is associated (independently of medication) with the development of certain metabolic disturbances and whether these might be explained by stress axis dysfunction.

Method Literature review.

Results Most studies did not control for confounding factors such as previous usage of medication, lifestyle, age and ethnicity. A few conducted in drug-naïve patients with first-episode schizophrenia appear to indicate that these patients have higher than expected rates of visceral obesity and impaired fasting glucose concentrations, which may be related to a subtle disturbance of the hypothalamic–pituitary–adrenal axis.

Conclusions Schizophrenia is independently associated with physical illnesses that have a metabolic signature. Therefore, patients need to have a thorough physical assessment at diagnosis and at regular intervals thereafter. Metabolic disturbances have been found in drug-naïve patients with first-episode illness and may be an inherent part of the illness.




This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
T. G. Dinan
Introduction
The British Journal of Psychiatry, April 1, 2004; 184(47): s53 - s54.
[Full Text] [PDF]